Diamine-bound receptor-specific cyclic peptides.

NI202200067APending Publication Date: 2026-08-07BOEHRINGER INGELHEIM INT GMBH
0 Cites 0 Cited by

Patent Information

Application Number
NI202200067
Authority / Receiving Office
NI · NI
Patent Type
Applications
Current Assignee / Owner
Filing Date
2022-08-02
Publication Date
2026-08-07
Patent Text Reader

Abstract

Receptor-specific cyclic peptides of formula (1), wherein Xaa1, Xaa2, Xaa3, x, R1, R2, R3, and R4 are as defined in the descriptive memorandum, compositions and formulations including the peptides of the above formula, and methods for preventing, improving, or treating melanocortin receptor-mediated diseases, indications, conditions, and syndromes using melanocortin receptor-specific cyclic peptides of formula 1.
Need to check novelty before this filing date? Find Prior Art